Access cutting-edge allergic conjunctivitis treatment through this clinical trial at a research site in Lincoln. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Lincoln location
Preparing your pre-screening questions…
Access allergic conjunctivitis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related allergic conjunctivitis treatment provided free
Check if you qualify for this allergic conjunctivitis clinical trial in Lincoln, NE
No-Cost Study Care
Local to Lincoln
Convenient for NE residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is researching 2 experimental drugs, REGN5713 and REGN5715. The study drugs will be either of these drugs given alone (either REGN5713 or REGN5715) or given together (REGN5713 and REGN5715) to reduce eye allergy signs and symptoms due to birch tree pollen allergy. The aim of the study is to see how safe and effective the study drugs are at lowering eye allergy signs and symptoms compared with placebo. The study will also evaluate whether the combination (REGN5713-5715) has different effectiveness than REGN5713 or REGN5715 alone. The study is looking at several other research questions, including: * What side effects may happen from taking the study drugs * How much of the study drugs is in the blood at different times * Whether the body makes antibodies against the study drugs (which could make the drug less effective or could lead to side effects)
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT07309432) has an active research site in Lincoln, NE that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for allergic conjunctivitis treatment options in Lincoln, NE, this clinical trial (NCT07309432) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lincoln research site is actively enrolling participants for this clinical trial. You'll receive care from experienced allergic conjunctivitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all allergic conjunctivitis clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Lincoln — not just this study.
Browse Leukemia Trials in Lincoln →